Frauke Schimmöller

Title: Frauke Schimmöller: Innovator in Alzheimer's Research

Introduction

Frauke Schimmöller is a notable inventor based in Menlo Park, CA (US). She has made significant contributions to the field of neuroscience, particularly in the study of Alzheimer's disease. With a total of 3 patents, her work focuses on innovative methods to combat neurological disorders.

Latest Patents

Frauke Schimmöller's latest patents revolve around a novel β-secretase and the modulation of β-secretase activity. The invention details a method for partially purifying this novel β-secretase and its application in assays designed to screen for potential drug candidates against Alzheimer's disease and other neurological conditions. The novel β-secretase is characterized by an estimated molecular weight of about 32-39 kDa or 22-26 kDa in HEK293 cell membrane extracts and human brain samples, respectively. This was calculated using radiation inactivation analysis, and it has a pH optimum at approximately pH 6.5-7.0.

Career Highlights

Throughout her career, Frauke has worked with prominent companies such as Scios Inc. and Eli Lilly and Company. Her experience in these organizations has allowed her to develop her expertise in the pharmaceutical and biotechnology sectors.

Collaborations

Frauke has collaborated with notable colleagues, including Ziyang Zhong and Barbara Cordell, who have contributed to her research endeavors.

Conclusion

Frauke Schimmöller's innovative work in the field of Alzheimer's research highlights her dedication to finding solutions for neurological diseases. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.